Nuevo 
Ver en grande
Ver en grande 
Bimekizumab
AM-M24662-1mg
Producto nuevo
Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation.
Al comprar este producto puede obtener hasta 45 puntos de fidelidad. Su cesta totalizará 45 puntos de fidelidad que se puede(n) transformar en un cupón de descuento de 9.00EUR.
Ficha de datos
| Size | 1mg |
| Storage Conditions | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Research Area | IL Receptor/Related |
| CAS Number | '1418205-77-2 |